255 related articles for article (PubMed ID: 37447279)
21. Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome.
Ates S; Aydın S; Ozcan P; Soyman Z; Gokmen Karasu AF; Sevket O
J Obstet Gynaecol; 2018 Feb; 38(2):236-240. PubMed ID: 28920502
[TBL] [Abstract][Full Text] [Related]
22. Adverse Effects of Selected Markers on the Metabolic and Endocrine Profiles of Obese Women With and Without PCOS.
Daghestani MH; Daghestani MH; Warsy A; El-Ansary A; Omair MA; Omair MA; Hassen LM; Alhumaidhi EM; Al Qahtani B; Harrath AH
Front Endocrinol (Lausanne); 2021; 12():665446. PubMed ID: 34122339
[TBL] [Abstract][Full Text] [Related]
23. The relationship between Polycystic ovary syndrome and vitamin D levels.
Yılmaz SA; Altınkaya SÖ; Kebabçılar A; Seçilmiş Kerimoğlu Ö; Tazegül Pekin A; Abuşoğlu S; Çelik Ç; Ünlü A
Turk J Obstet Gynecol; 2015 Mar; 12(1):18-24. PubMed ID: 28913035
[TBL] [Abstract][Full Text] [Related]
24. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L
Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
[TBL] [Abstract][Full Text] [Related]
25. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
[TBL] [Abstract][Full Text] [Related]
26. Associations of vitamin D concentration with metabolic and hormonal indices in women with polycystic ovary syndrome presenting abdominal and gynoidal type of obesity.
Kozakowski J; Kapuścińska R; Zgliczyński W
Ginekol Pol; 2014 Oct; 85(10):765-70. PubMed ID: 25546928
[TBL] [Abstract][Full Text] [Related]
27. Is acne a sign of androgen excess disorder or not?
Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
[TBL] [Abstract][Full Text] [Related]
28. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
29. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls.
Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
J Clin Endocrinol Metab; 2011 Jul; 96(7):2178-85. PubMed ID: 21508129
[TBL] [Abstract][Full Text] [Related]
30. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
31. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
van der Westhuizen S; van der Spuy ZM
Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
[TBL] [Abstract][Full Text] [Related]
32. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
33. CLINICAL AND ENDOCRINE ALTERATIONS IN WOMEN WITH POLYCYSTIC OVARY SYNDROME.
Kotori M; Ferizi-Shabani L; Koçinaj A; Ferizi V; Kotori J
Georgian Med News; 2024 Jan; (346):10-13. PubMed ID: 38501614
[TBL] [Abstract][Full Text] [Related]
34. Reproductive Hormones and Anthropometry: A Follow-Up of PCOS and Controls From Perimenopause to Older Than 80 Years.
Forslund M; Schmidt J; Brännström M; Landin-Wilhelmsen K; Dahlgren E
J Clin Endocrinol Metab; 2021 Jan; 106(2):421-430. PubMed ID: 33205205
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
Adams JM; Taylor AE; Crowley WF; Hall JE
J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
[TBL] [Abstract][Full Text] [Related]
36. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
[TBL] [Abstract][Full Text] [Related]
37. Hormonal and metabolic aspects of acne vulgaris in women with polycystic ovary syndrome.
Franik G; Bizoń A; Włoch S; Kowalczyk K; Biernacka-Bartnik A; Madej P
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4411-4418. PubMed ID: 30058676
[TBL] [Abstract][Full Text] [Related]
38. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA; Korbonits M; Isidori AM; Webb JA; Trainer PJ; Monson JP; Besser GM; Grossman AB
Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
Falsetti L; Galbignani E
Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
[TBL] [Abstract][Full Text] [Related]
40. Sonographic parameters and hormonal status in lean and obese women with polycystic ovary syndrome.
Sengos C; Andreakos C; Iatrakis G
Clin Exp Obstet Gynecol; 2000; 27(1):35-8. PubMed ID: 10758797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
